Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma: screening and therapy.

M Rizzetto1

  • 1Università degli Studi--Torino, Dipartimento di Gastroenterologia.

Minerva Gastroenterologica E Dietologica
|February 25, 2006
PubMed
Summary

Liver cancer treatment is challenging due to late diagnosis and limited options. Advanced liver cancer patients often benefit from palliative treatments like surgical resection, percutaneous ethanol injection (PEI), and transarterial chemoembolization (TACE).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of hepatitis D: an unmet medical need.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D - authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response.

Alimentary pharmacology & therapeutics·2016
Same author

Hepatorenal syndrome after treatment of visceral leishmaniasis requiring terlipressin therapy.

Minerva gastroenterologica e dietologica·2015
Same author

Antiviral treatment discontinuation among hepatitis C-infected individuals with thrombocytopenia.

Journal of viral hepatitis·2015
Same author

Letter: renal effects of tenofovir in adefovir dipivoxil-experienced HBV patients.

Alimentary pharmacology & therapeutics·2014

Area of Science:

  • Hepatology
  • Oncology
  • Surgical Gastroenterology

Background:

  • Liver cancer (LC) treatment is often complicated by late-stage diagnosis.
  • Cirrhosis frequently coexists, limiting surgical resection options.
  • Chemotherapy is largely ineffective, and liver transplant indications are uncertain due to cost and recurrence risks.

Purpose of the Study:

  • To review current treatment strategies for liver cancer.
  • To highlight the challenges in managing advanced liver cancer.
  • To discuss the role of various therapeutic modalities.

Main Methods:

  • Review of existing literature on liver cancer treatment modalities.
  • Discussion of surgical resection, orthotopic liver transplant, palliative treatments (PEI, TACE), proton radiotherapy, and thermal ablation.

Related Experiment Videos

  • Exploration of combined therapy approaches.

    • Main Results:

    • Surgical resection is optimal for tumors in healthy livers.
    • Orthotopic liver transplant is indicated for cirrhotic patients with small tumors (<2-3 cm).
    • Palliative treatments (PEI, TACE) are crucial for advanced stages (TNM III/IV) due to organ scarcity.

    Conclusions:

    • Advanced liver cancer management requires tailored approaches.
    • Palliative therapies and innovative methods like proton radiotherapy and thermal ablation can slow disease progression.
    • Combined therapies may offer the best outcomes for selected patients.